Your session is about to expire
← Back to Search
TAP block with 0.25% bupivacaine for Infections (TOTEM Trial)
N/A
Waitlist Available
Led By Melinda Abernethy, MD
Research Sponsored by Western Michigan University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 72 hours post operation
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether a new type of pain medication works better than the standard pain medication for a specific type of surgery.
Eligible Conditions
- Infections
- Postoperative Pain
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 72 hours post operation
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~72 hours post operation
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Pain
Pain
Pain rating 4 hours post operation
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TAP block with 0.25% bupivacaineExperimental Treatment1 Intervention
Standard comparator
Group II: TAP block with liposomal bupivacaineActive Control1 Intervention
Active comparator
Find a Location
Who is running the clinical trial?
Western Michigan University School of MedicineLead Sponsor
5 Previous Clinical Trials
503 Total Patients Enrolled
Melinda Abernethy, MD5.04 ReviewsPrincipal Investigator - Western Michigan University Homer Stryker M.D. School of Medicine
Western Michigan University School of Medicine
5Patient Review
This doctor is excellent. They are very professional and take the time to listen to their patients. I would highly recommend them to anyone.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger